Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00636363 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution
A NA study of Contact Lens Solutions, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 541
- Enrollment target
- 1
- Study location
NCT00636363: Completed NA study of Contact Lens Solutions, sponsored by Bausch & Lomb Incorporated.
NCT00636363 is a NA study of Contact Lens Solutions that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 541 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00636363, a NA study of Contact Lens Solutions, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 541 participants
- Enrollment target
- 1
- Study location
Study Summary
To the safety and efficacy of a Bausch \& Lomb Multipurpose Solution when compared to Ciba vision Aquify Multipurpose solution
Primary Outcome
eyes with any slit lamp findings greater than Grade 2 at any visit. Slit lamp findings for each eye will be graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). Epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, superior tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates will be assessed.
Conditions Studied
Interventions
- DEVICE Bausch & Lomb Multipurpose Solution - Rub Care
- DEVICE Bausch & Lomb Multipurpose Solution - No Rub Care
- DEVICE Ciba Vision Aquify Multipurpose Solution
Study Locations (1)
New York
- Place Eye Care - Le Roy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-08 |
| Phase | NA |
What the finished NCT00636363 record still lists
NCT00636363 is an interventional study that assigns participants to a tested intervention. The registered 541 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Contact Lens Solutions appearing as the primary indexed condition, and to 3 interventions - of which Bausch & Lomb Multipurpose Solution - Rub Care is the first listed.
NCT00636363 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00636363 about?
NCT00636363 is a clinical study titled "Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution". To the safety and efficacy of a Bausch \& Lomb Multipurpose Solution when compared to Ciba vision Aquify Multipurpose solution
What is the current status of trial NCT00636363?
This trial is currently completed. It is a NA study. The enrollment target is 541 participants. The study started on 2008-03. Estimated completion is 2008-08.
What conditions does trial NCT00636363 study?
This clinical trial studies the following conditions: Contact Lens Solutions.
What interventions are being tested in trial NCT00636363?
The interventions under investigation include: Bausch & Lomb Multipurpose Solution - Rub Care (DEVICE), Bausch & Lomb Multipurpose Solution - No Rub Care (DEVICE), Ciba Vision Aquify Multipurpose Solution (DEVICE).
Who is sponsoring clinical trial NCT00636363?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00636363 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00636363's enrollment target sits among peer trials
541 187th of 2000 higher than 1,814 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04929223 · 542 participants · Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- NCT05584670 · 542 participants · Phase 1
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia